Inventor
XU MEIZHONG
US40 patents
⚠️ This page may combine multiple inventors who share the name “XU MEIZHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
29 patentsUS7767675B2Aug 3, 2010
Imidazotriazines and imidazopyrimidines as kinase inhibitors
INCYTE CORP85 citations99
US9533984B2Jan 3, 2017
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP42 citations98
US9533954B2Jan 3, 2017
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP42 citations98
US7776874B2Aug 17, 2010
Amido compounds and their use as pharmaceuticals
INCYTE CORP27 citations96
US7304081B2Dec 4, 2007
Amido compounds and their use as pharmaceuticals
INCYTE CORP42 citations96
US10947230B2Mar 16, 2021
Bicyclic heterocycles as FGFR inhibitors
INCYTE CORP26 citations94
US10813930B2Oct 27, 2020
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP27 citations94
US10793565B2Oct 6, 2020
Heterocyclic compounds as immunomodulators
INCYTE CORP27 citations94
US10213427B2Feb 26, 2019
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
INCYTE CORP34 citations94
US9695168B2Jul 4, 2017
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
INCYTE CORP27 citations94
US9266892B2Feb 23, 2016
Fused pyrazoles as FGFR inhibitors
INCYTE CORP40 citations94
US7723349B2May 25, 2010
Aza spiro alkane derivatives as inhibitors of metalloproteases
INCYTE CORP21 citations93
US7683060B2Mar 23, 2010
Triazolotriazines as kinase inhibitors
INCYTE CORP25 citations92
US7687665B2Mar 30, 2010
2-methylprop anamides and their use as pharmaceuticals
INCYTE CORP24 citations90
US11566026B2Jan 31, 2023
Heterocyclic compounds as immunomodulators
INCYTE CORP16 citations86
US10640503B2May 5, 2020
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
INCYTE CORP7 citations84
US9957229B2May 1, 2018
Amido compounds and their use as pharmaceuticals
INCYTE CORP4 citations84
US9801877B2Oct 31, 2017
AZA spiro alkane derivatives as inhibitors of metalloproteases
INCYTE CORP7 citations84
US8039471B2Oct 18, 2011
Aza spiro alkane derivatives as inhibitors of metalloproteases
INCYTE CORP5 citations74
US7915408B2Mar 29, 2011
Triazolotriazines as kinase inhibitors
INCYTE CORP6 citations74
US10738052B2Aug 11, 2020
Imidazotriaines and imidazopyrimidines as kinase inhibitors
INCYTE CORP3 citations73
US10047086B2Aug 14, 2018
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
INCYTE CORP2 citations73
US9403775B2Aug 2, 2016
AZA spiro alkane derivatives as inhibitors of metalloproteases
INCYTE CORP3 citations73
US11472791B2Oct 18, 2022
Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
INCYTE CORP7 citations72
US12084449B2Sep 10, 2024
Imidazotriazines and imidazopyrimidines as kinase inhibitors
INCYTE CORP0 citations63
US11261191B2Mar 1, 2022
Imidazotriaines and imidazopyrimidines as kinase inhibitors
INCYTE CORP0 citations63
US12466828B2Nov 11, 2025
Bicyclic amines as CDK2 inhibitors
INCYTE CORP0 citations60
US10226459B2Mar 12, 2019
Aza spiro alkane derivatives as inhibitors of metalloproteases
INCYTE CORP0 citations52
US9670154B2Jun 6, 2017
Amido compounds and their use as pharmaceuticals
INCYTE CORP0 citations52
YAO WENQING
8 patentsUS8754114B2Jun 17, 2014
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
YAO WENQING49 citations98
US9126927B2Sep 8, 2015
Amido compounds and their use as pharmaceuticals
YAO WENQING20 citations92
US8071624B2Dec 6, 2011
N-substituted piperidines and their use as pharmaceuticals
YAO WENQING26 citations92
US8058288B2Nov 15, 2011
Amido compounds and their use as pharmaceuticals
YAO WENQING22 citations92
US8637497B2Jan 28, 2014
AZA spiro alkane derivatives as inhibitors of metalloproteases
YAO WENQING4 citations84
US8110581B2Feb 7, 2012
Lactam compounds and their use as pharmaceuticals
YAO WENQING2 citations63
US8563570B2Oct 22, 2013
Lactam compounds and their use as pharmaceuticals
YAO WENQING0 citations52
US8288417B2Oct 16, 2012
N-substituted piperidines and their use as pharmaceuticals
YAO WENQING0 citations52